ArticleTherapie

A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19.

Chia Siang Kow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.